Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persist in vivo
D. Palianina, J. Mietz, C. Stuehler, B. Arnold, G. R. Bantug, C. Münz, O. Chijioke, N. Khanna
This study develops a protocol to expand EBV-specific stem cell memory T cells, showing improved tumor control and persistence in a PTLD model compared to existing ACT methods.
bioRxiv · May 30, 2023 · PreprintImmunology